https://www.selleckchem.com/pr....oducts/nvp-dky709.ht
New-onset post-operative atrial fibrillation (POAF) is a frequent adverse event following major thoracic surgery and is associated with increased risk of perioperative morbidity, length of stay and stroke. It is managed initially with rate and rhythm control therapy; however, optimal duration and the need for anticoagulation are poorly understood. This study aims to assess practice variation regarding POAF management and duration. This retrospective, single-center cohort study included patients who underwent major thoracic surgery an
Like
Comment
Share
